Future Watch: Gene & Cell Therapy
A Revolution In Medicine And Healthcare Blog

Current Blog Category: HIV/AIDS Research
The Death of the Regulatory Barrier to Better Medicine

The Death of the Regulatory Barrier to Better Medicine

Jul 7, 2020

Written by Jeff Galvin, CEO of American Gene Technologies® The birth of high-value therapeutics and cures Does the development of effective drugs have to be incredibly expensive?  Maybe not anymore. There is a new type of drug development emerging: Gene Therapy. The hallmark of gene therapy…

Read More
What Impact Did the Stock Market Crash Have on Biotech Stocks?

What Impact Did the Stock Market Crash Have on Biotech Stocks?

May 13, 2020

Contributing Author John Vandermosten, Senior Biotechnology Analyst Examining events of the past can give us a sense of what to expect in the periods ahead. And despite the omnipresent warning that “past performance is not indicative of future results” we will share some historical trends on…

Read More
Jeff Galvin, CEO of American Gene Technologies, presents Can We Reprogram the Human Computer? at the Parenteral Drug Association's 2020 Annual Meeting

Gene Therapy Technology – Reprogramming The Human Computer

May 8, 2020

Subscribe to our YouTube Channel “We are at the beginning of the technology curve in pharmaceuticals.” Jeff Galvin, CEO of American Gene Technologies (AGT), explains his ascent into the biotechnology drug development field after working closely with computers in Silicon Valley for a large part…

Read More
HIV IMMUNITY Dr. Hardy Shares the Possibilities of Gene Therapy

HIV IMMUNITY Dr. Hardy Shares the Possibilities of Gene Therapy

May 8, 2020

Subscribe to our YouTube Channel Contrary to antiretroviral drugs, gene therapy could be used to give the human body immunity to HIV. Dr. David Hardy, a member of American Gene Technologies (AGT)’s HIV Scientific Advisory Board, tells his story of his lifelong commitment to mitigate…

Read More
Vice President Irene Tennant explains how companies are developing cures for rare diseases with gene therapy

Using Gene Therapy to Cure Diseases, Irene Tennant, VP of AGT

Apr 23, 2020

Irene Tennant, the head of clinical development and regulatory affairs at AGT, speaks about her role in the development of gene and cell therapies to treat human diseases. She works to progress potential therapies into the clinic, and ultimately to the bedsides of thousands of…

Read More
Jeff Galvin and Irene Tennant have a conversation about their work at American Gene Technologies (AGT), a gene therapy company built to cure diseases that were previously thought of as incurable

Progression of a Gene Therapy Company, Jeff Galvin, CEO and Irene Tennant, VP of AGT

Apr 23, 2020

In this video, Jeff Galvin and Irene Tennant have a conversation about their work at American Gene Technologies (AGT), a gene therapy company, built to cure diseases that were previously thought of as incurable. The mission statement of the company is to “reduce human suffering…

Read More
CEO Jeff Galvin explains how American Gene Technologies uses genetic modifications in the body to change how viral diseases interact with the immune system

About Gene Therapy, Jeff Galvin, CEO of AGT

Apr 23, 2020

In this video, Jeff Galvin explains how American Gene Technologies (AGT) uses genetic modifications in the body to change how viral diseases interact with the immune system.   Jeff Galvin, CEO of AGT, explains how he believes gene therapy is developing in a similar way…

Read More
CEO Jeff Galvin explains how gene therapy is a revolution in medicine

Cell and Gene Therapy Approach, Jeff Galvin, CEO of AGT

Apr 23, 2020

Gene therapy is accelerating at an incredibly fast and impressive rate. AGT is at the forefront of this progress, fuelling the gene therapy market.   Jeff Galvin, CEO of AGT, explains how he believes gene therapy is developing in a similar way to that of…

Read More
Chief Science Officer C. David Pauza explains the ins and outs of cell therapy

Cell Therapy Manufacturing, C. David Pauza, Ph.D., CSO of AGT

Apr 22, 2020

This video explains the ins and outs of cell therapy. Dr. C. David Pauza, Chief Science Officer of American Gene Technologies, explains how one tiny dot on a cell, a virus, can kill a person, but this dot can be changed from the infectious root…

Read More
Benefits of FDA Orphan Drug Designation: What You Need to Know

Benefits of FDA Orphan Drug Designation: What You Need to Know

Apr 6, 2020

by Irene TennantVP of Clinical Product Development and Regulatory Affairs Developing treatments for rare diseases has many challenges. These challenges are different and, in many ways, more complex than what is experienced during development of a drug intended for a larger patient population. The complexities…

Read More

Subscribe to Receive our Blog Updates

Subscribe to our blog updates to be notified when we release new content!

Blog Categories

Follow AGT on Social Media